Ramipril Capsule
Product Images NDC 71335-9645

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 71335-9645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Ramipril (9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 01)

Structural Formula For Ramipril (9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 01)
Chemical structure of Ramipril showing its molecular framework including a phenyl group, ester, amide, and cyclic components, consistent with its designation as an ACE inhibitor active ingredient.*
FDA Label Image

Graph1 (9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 02)

Graph1 (9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 02)
A line graph showing the proportion of patients over days of follow-up for Ramipril versus placebo. The x-axis represents days of follow-up up to about 1600 days, and the y-axis represents the proportion of patients from 0.00 to 0.20. The graph includes two lines: a solid line for Ramipril and a dashed line for placebo, with a noted p-value of 0.0001 indicating statistical comparison.*
FDA Label Image

Graph2 (9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 03)

Graph2 (9fb6ade9 C326 4291 A3d4 Dfc2502c29ab 03)
A forest plot chart showing the relative risk in the Ramipril group compared to a placebo group across various patient subgroups. The chart lists subgroups such as cardiovascular disease, diabetes, age, sex, hypertension, coronary artery disease history, myocardial infarction history, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. It presents the number of patients and the incidence of composite outcomes in the placebo group, with relative risk estimates and 95% confidence intervals indicated by squares and horizontal lines aligned against a vertical line at 1.0.*
FDA Label Image

Label (Lbl713359645)

Label (Lbl713359645)
Ramipril 5 mg Capsule packaging label by Bryant Ranch Prepack, identified as a red capsule. The label compares to Altace 5 mg Capsule, from Lupin Limited, with a quantity of 30 capsules. Storage instructions indicate room temperature 20°-25°C (68°-77°F). Includes a barcode and warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.